Phase II/pharmacodynamic trial of dose-intensive, weekly parenteral hydroxyurea and fluorouracil administered with interferon alfa-2a in patients with refractory malignancies of the gastrointestinal tract.
暂无分享,去创建一个
R. Ladner | S. Wadler | A. Murgo | R. Schechner | R. Kaleya | H. Haynes | S. Damle | R. Berkenblit